Advertisement
Home »

Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community.

Jul 25, 2023

ABOUT THE EXPERTS

  • Sara Alamyar

    Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia.

    Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, Australia.

    Elizabeth Azzi

    Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, Australia.

    GSK Australia, Pty., Ltd., Ermington, NSW 2115, Australia.

    Pamela Srour-Alphonse

    Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, Australia.

    Rachel House

    Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, Australia.

    Biljana Cvetkovski

    Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, Australia.

    Vicky Kritikos

    Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, Australia.

    Sinthia Bosnic-Anticevich

    Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW 2006, Australia.

    Sydney Pharmacy School, The University of Sydney, Sydney, NSW 2006, Australia.

    Sydney Local Health District, Sydney, NSW 2050, Australia.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement